Late and Long-lasting Response in an Adult Chronic Idiopathic Thrombocytopenic Purpura after Extended Course of Rituximab

Giovanni D'Arena Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

Maria Luigia Vigliotti Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

Mariarosa Coccaro Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

Giovanni Iodice Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

Alfredo Tartarone Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

Rosella Matera Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

Nicola Di Renzo Hematology and Oncology Unit, C.R.O.B. Regional Hospital, 85028 Rionero in Vulture (Pz), Italy

show all

Stasi, R., Pagano, A., Stipa, E. and Amadori, S. (2001) "Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura", Blood 98, 952-957.
Google Scholar
Stasi, R., Stipa, E., Forte, V, Meo, P. and Amadori, S. (2002) "Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura", Blood 99, 3872-3873.
Google Scholar
Cines, D.B. and Blanchette, VS. (2002) "Immune thrombocytopenic purpura". The New England Journal of Medicine 346, 995-1008.
Google Scholar
Faurschou, M., Hasselbach, H.C. and Nielsen, O.J. (2001) "Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia", European Journal of Haematology 66, 408-411.
Google Scholar
Delgado, J., Bustos, I.G., limenez-Yuste, V and Hemandez-Navarro, F. (2002) "Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura", Haematologica 87, 215-216.
Google Scholar
Cohen, Y. and Polliack, A. (2002) "Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITF) of 10 years duration after only two infusions of rituximab", The Hematology Journal 3, 61-62.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Late and Long-lasting Response in an Adult Chronic Idiopathic Thrombocytopenic Purpura after Extended Course of Rituximab

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Late and Long-lasting Response in an Adult Chronic Idiopathic Thrombocytopenic Purpura after Extended Course of Rituximab

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date